{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:38:40Z","timestamp":1789079920462,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2017477"],"award-info":[{"award-number":["A2017477"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030310203"],"award-info":[{"award-number":["2017A030310203"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In our previous report, we identified miR-34c-3p as an independent factor contributing to the carcinogenesis of hepatocellular carcinoma (HCC) by targeting NCK Associated Protein 1 (NCKAP1). NCKAP1 has been known to promote the malignancy of cancer cells by disrupting the structural stability of WAS protein family member 1 (WASF1) and is correlated with poor prognosis of patients in several cancer types. Our results, however, show that NCKAP1 is correlated with a favorable outcome in HCC patients. The underlying mechanism of this contradictory phenomenon is unknown. The current study was designed to explore the mechanism of NCKAP1 in HCC. As a result, clinicopathological correlations and results from in vivo and in vitro models indicated that NCKAP1 was a tumor suppressor gene. Cell cycle analysis suggested that NCKAP1 inhibit cells from entering G2\/M phase. Western blot analysis showed that WASF1 was barely expressed in HCC cell lines compared to that of breast cancer cell lines, which serve as positive controls. Furthermore, Rb1 and p53 expression was upregulated in cell lines overexpressing NCKAP1. Expression of several cell cycle regulating proteins also varied in the HCC cell lines. In conclusion, although previous studies have identified NCKAP1 as a cell invasion promoter by binding to WASF1, we found that NCKAP1 is a tumor suppress gene that modulates the cell cycle of HCC cell lines by targeting Rb1\/p53 regulation.<\/jats:p>","DOI":"10.1038\/s41419-019-1603-4","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:16:27Z","timestamp":1557414987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1\/p53 activation in hepatocellular carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiao-ping","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-hong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-he","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/path.4376","volume":"233","author":"SL Anwar","year":"2014","unstructured":"Anwar, S. L. et al. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma. J. Pathol. 233, 392\u2013401 (2014).","journal-title":"J. Pathol."},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.25987","volume":"57","author":"W Ma","year":"2013","unstructured":"Ma, W., Wong, C. C., Tung, E. K., Wong, C. M. & Ng, I. O. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho\/Rho-kinase\/myosin phosphatase target pathway. Hepatology 57, 152\u2013161 (2013).","journal-title":"Hepatology"},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1038\/sj.onc.1209913","volume":"25","author":"OA Kent","year":"2006","unstructured":"Kent, O. A. & Mendell, J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188\u20136196 (2006).","journal-title":"Oncogene"},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ng1590","volume":"37","author":"I Bentwich","year":"2005","unstructured":"Bentwich, I. et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nature Genet. 37, 766\u2013770 (2005).","journal-title":"Nature Genet."},{"key":"1603_CR6","first-page":"257","volume":"629","author":"M Sioud","year":"2010","unstructured":"Sioud, M. & Cekaite, L. Profiling of miRNA expression and prediction of target genes. Methods Mol. Biol. 629, 257\u2013271 (2010).","journal-title":"Methods Mol. Biol."},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1167\/iovs.09-3520","volume":"50","author":"CL Dalgard","year":"2009","unstructured":"Dalgard, C. L., Gonzalez, M., deNiro, J. E. & O\u2019Brien, J. M. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Investig. Ophthalmol. Vis. Sci. 50, 4542\u20134551 (2009).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/cgt.2008.8","volume":"15","author":"AW Tong","year":"2008","unstructured":"Tong, A. W. & Nemunaitis, J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 15, 341\u2013355 (2008).","journal-title":"Cancer Gene Ther."},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-12-2728","volume":"19","author":"R Wei","year":"2013","unstructured":"Wei, R. et al. Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma. Clin. Cancer Res. 19, 4780\u20134791 (2013).","journal-title":"Clin. Cancer Res."},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00432-016-2280-7","volume":"143","author":"CZ Xiao","year":"2017","unstructured":"Xiao, C. Z. et al. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. J. Cancer Res. Clin. Oncol. 143, 263\u2013273 (2017).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1006\/geno.1999.6053","volume":"63","author":"T Suzuki","year":"2000","unstructured":"Suzuki, T. et al. Molecular cloning of a novel apoptosis-related gene, human Nap1 (NCKAP1), and its possible relation to Alzheimer disease. Genomics 63, 246\u2013254 (2000).","journal-title":"Genomics"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1097\/00001756-199412000-00031","volume":"5","author":"JH Su","year":"1994","unstructured":"Su, J. H., Anderson, A. J., Cummings, B. J. & Cotman, C. W. Immunohistochemical evidence for apoptosis in Alzheimer\u2019s disease. Neuroreport 5, 2529\u20132533 (1994).","journal-title":"Neuroreport"},{"issue":"Pt 3","key":"1603_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1042\/bj3220873","volume":"322","author":"Y Kitamura","year":"1997","unstructured":"Kitamura, Y. et al. Interaction of Nck-associated protein 1 with activated GTP-binding protein Rac. Biochem. J. 322(Pt 3), 873\u2013878 (1997).","journal-title":"Biochem. J."},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"9536","DOI":"10.1073\/pnas.0603786103","volume":"103","author":"GM Rivera","year":"2006","unstructured":"Rivera, G. M. et al. Requirement of Nck adaptors for actin dynamics and cell migration stimulated by platelet-derived growth factor B. Proc. Natl Acad. Sci. USA 103, 9536\u20139541 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nature00859","volume":"418","author":"S Eden","year":"2002","unstructured":"Eden, S., Rohatgi, R., Podtelejnikov, A. V., Mann, M. & Kirschner, M. W. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418, 790\u2013793 (2002).","journal-title":"Nature"},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/0008-5472.CAN-16-0562","volume":"76","author":"Y Teng","year":"2016","unstructured":"Teng, Y., Qin, H., Bahassan, A., Bendzunas, N. G., Kennedy, E. J. & Cowell, J. K. The WASF3-NCKAP1-CYFIP1 complex is essential for breast cancer metastasis. Cancer Res. 76, 5133\u20135142 (2016).","journal-title":"Cancer Res."},{"key":"1603_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-453","volume":"13","author":"Y Teng","year":"2013","unstructured":"Teng, Y., Xie, X., Walker, S., White, D. T., Mumm, J. S. & Cowell, J. K. Evaluating human cancer cell metastasis in zebrafish. BMC Cancer 13, 453 (2013).","journal-title":"BMC Cancer"},{"key":"1603_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.bjc.6605850","volume":"103","author":"Y Teng","year":"2010","unstructured":"Teng, Y., Ren, M. Q., Cheney, R., Sharma, S. & Cowell, J. K. Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br. J. Cancer 103, 1066\u20131075 (2010).","journal-title":"Br. J. Cancer"},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2353\/ajpath.2007.060975","volume":"170","author":"K Sossey-Alaoui","year":"2007","unstructured":"Sossey-Alaoui, K. et al. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am. J. Pathol. 170, 2112\u20132121 (2007).","journal-title":"Am. J. Pathol."},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/bjc.2016.18","volume":"114","author":"ME Lomakina","year":"2016","unstructured":"Lomakina, M. E. et al. Arpin downregulation in breast cancer is associated with poor prognosis. Br. J. Cancer 114, 545\u2013553 (2016).","journal-title":"Br. J. Cancer"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"117906441771319","DOI":"10.1177\/1179064417713197","volume":"10","author":"JK Cowell","year":"2017","unstructured":"Cowell, J. K., Teng, Y., Bendzunas, N. G., Ara, R., Arbab, A. S. & Kennedy, E. J. Suppression of breast cancer metastasis using stapled peptides targeting the WASF regulatory complex. Cancer Growth and Metastasis 10, 1179064417713197 (2017).","journal-title":"Cancer Growth and Metastasis"},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1083\/jcb.200407076","volume":"168","author":"H Yamaguchi","year":"2005","unstructured":"Yamaguchi, H. et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2\/3 complex pathway and cofilin. J. Cell Biol. 168, 441\u2013452 (2005).","journal-title":"J. Cell Biol."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cub.2012.11.059","volume":"23","author":"H Tang","year":"2013","unstructured":"Tang, H. et al. Loss of Scar\/WAVE complex promotes N-WASP- and FAK-dependent invasion. Curr. Biol. 23, 107\u2013117 (2013).","journal-title":"Curr. Biol."},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/jcp.24329","volume":"228","author":"R Di Fiore","year":"2013","unstructured":"Di Fiore, R., D\u2019Anneo, A., Tesoriere, G. & Vento, R. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis. J. Cell. Physiol. 228, 1676\u20131687 (2013).","journal-title":"J. Cell. Physiol."},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1101\/gad.282145.116","volume":"30","author":"NJ Dyson","year":"2016","unstructured":"Dyson, N. J. RB1: a prototype tumor suppressor and an enigma. Genes Dev. 30, 1492\u20131502 (2016).","journal-title":"Genes Dev."},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aah4199","volume":"355","author":"SY Ku","year":"2017","unstructured":"Ku, S. Y. et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355, 78\u201383 (2017).","journal-title":"Science"},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/ijc.11254","volume":"106","author":"Y Edamoto","year":"2003","unstructured":"Edamoto, Y. et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int. J. Cancer 106, 334\u2013341 (2003).","journal-title":"Int. J. Cancer"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(91)90181-W","volume":"67","author":"DW Goodrich","year":"1991","unstructured":"Goodrich, D. W., Wang, N. P., Qian, Y. W., Lee, E. Y. & Lee, W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293\u2013302 (1991).","journal-title":"Cell"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222\u2013231 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.gde.2005.07.001","volume":"15","author":"M Korenjak","year":"2005","unstructured":"Korenjak, M. & Brehm, A. E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr. Opin. Genet. Dev. 15, 520\u2013527 (2005).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1603_CR31","first-page":"131","volume":"14","author":"L Stone","year":"2017","unstructured":"Stone, L. Prostate cancer: Hand in hand - Rb1 and Trp53 cooperate to suppress resistance. Nature reviews. Urology 14, 131 (2017).","journal-title":"Urology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1603-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:01:34Z","timestamp":1671210094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1603-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1603-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study participants (or their parents or guardians) provided written informed consent. The study protocol was approved by the research institute\u2019s committee on human research. All animal experiments conformed to internationally accepted standards and were approved by the appropriate institutional review body.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}}],"article-number":"369"}}